Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
(NQ:
)
N/A
UNCHANGED
Last Price
Updated:
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
10 stocks that are pushing the Nasdaq to 5,000
February 23, 2015
Biotech and medical-device companies are leading the charge, with gains up to 265%, writes Phil van Doorn.
Tags
Medical Products
Telecommunications
NLST
From
MarketWatch
Taglich Brothers Initiates Coverage on Apricus Biosciences, Inc.
February 23, 2015
From
Marketwired News Releases
Taglich Brothers Initiates Coverage with Speculative Buy Recommendation on Apricus Biosciences - Video Research Alert on InvestmentPitch.com
February 20, 2015
From
Newsfile Corp News Releases
Apricus Biosciences Announces $11 Million Registered Direct Offering With Sarissa Capital Management LP
February 10, 2015
From
GlobeNewswire News Releases
Apricus Biosciences Expands Exclusive License Agreement With an Existing Partner to Market Vitaros(R) in Select Asia-Pacific Countries
February 03, 2015
Apricus Eligible to Receive an Additional Upfront, Milestone Payment and a Double-Digit Royalty on Net Sales
From
GlobeNewswire News Releases
Apricus Biosciences to Present at the 17th Annual BIO CEO & Investor Conference
February 03, 2015
From
GlobeNewswire News Releases
Morning Market Gainers
January 28, 2015
ABIOMED, Inc. (NASDAQ: ABMD) shares jumped 34.96% to $52.13 after the company reported upbeat quarterly results and raised its ...
Tags
X
BABA
Movers
From
Benzinga
Wednesday Morning Movers: Apple Climbing Following Record-Breaking Earnings
January 28, 2015
Apricus Biosciences Inc(NASDAQ: APRI) +21% - Announces issuance of U.S. patents for Rayva. Apple Inc. (NASDAQ: AAPL) +8% - ...
Tags
ACAT
SSRI
HES
From
Benzinga
Apricus Biosciences Announces Issuance of U.S. Patent for RayVa(TM)
January 27, 2015
From
GlobeNewswire News Releases
Apricus Biosciences Announces the Appointment of Catherine Bovenizer as Vice President of Finance, Chief Accounting Officer
January 11, 2015
From
GlobeNewswire News Releases
Building Value: Apricus Biosciences Report Issued by BrokerBank Securities, Inc.
January 08, 2015
From
PR Newswire
Apricus Biosciences to Present at Biotech Showcase 2015
January 05, 2015
From
GlobeNewswire News Releases
Apricus Biosciences Offers Year-End '14 Update; in '15 Plans to Advance Clinical Pipeline, Further Commercialization of ED Drug Vitaros(R)
December 21, 2014
Apricus Biosciences, Inc. (Nasdaq: APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, ...
Tags
APRI
Benzinga
News
From
Benzinga
Apricus Biosciences Announces Year-End 2014 Update and 2015 Plans to Advance Its Clinical Pipeline and Further Commercialize Its Erectile Dysfunction Drug Vitaros(R)
December 21, 2014
From
GlobeNewswire News Releases
Apricus Biosciences Appoints Barbara Troupin, M.D. as Chief Medical Officer
December 14, 2014
Company Also Announces Additional Senior Management Change
From
GlobeNewswire News Releases
APRI Announces First Patient Enrolled In Phase 2a Trial For RayVa; Keryx Announces Issuance Of New U.S. Patent For Auryxia
December 04, 2014
A look at some of the headlines for companies that made news in the healthcare sector on December 4, 2014, including APRI, KERX, ALDX, CCXI
Tags
Pharma/Biotech
Stocks / Equities
Healthcare
From
Blogs - TalkMarkets
Apricus Biosciences Announces First Patient Enrolled in Phase 2a Clinical Trial for RayVa(TM) in Patients With Raynaud's Phenomenon
December 03, 2014
From
GlobeNewswire News Releases
Apricus Biosciences Appoints Brian T. Dorsey as Chief Development Officer
December 01, 2014
Company Also Announces Management Changes
From
GlobeNewswire News Releases
Apricus Biosciences Announces Third Quarter 2014 Financial Results and Provides Corporate Update
November 09, 2014
From
GlobeNewswire News Releases
Apricus Biosciences to Present at Three Upcoming Investor Conferences in November and December of 2014
November 04, 2014
All Presentations Will be Available Via Webcast
From
GlobeNewswire News Releases
Apricus Biosciences Announces Corporate Update and Third Quarter 2014 Financial Results Conference Call
November 03, 2014
Conference Call and Webcast to be Held Monday, November 10, 2014 at 8:30 a.m. ET
From
GlobeNewswire News Releases
Apricus Biosciences Announces the Launch of Its Novel Topical Treatment for Erectile Dysfunction in Belgium by Sandoz
November 02, 2014
To Be Commercialized in Belgium as Vytaros(R), Following Successful Launches in the United Kingdom, Sweden and Germany as Vitaros(R) Earlier This Year
From
GlobeNewswire News Releases
Morning Market Movers
October 20, 2014
SinoCoking Coal and Coke Chemical Industries (NASDAQ: SCOK) shares jumped 43.66% to $3.38 as aboveground syngas facility commenced ...
Tags
SHOR
Movers
ACTG
From
Benzinga
Apricus Expands Development Pipeline With the In-Licensing of U.S. Rights for Fispemifene, a Phase 2b Ready Asset, From Forendo Pharma Targeting Urological Conditions in Men
October 19, 2014
From
GlobeNewswire News Releases
Morning Market Losers
October 13, 2014
ALCO Stores (NYSE: ALCS) shares slipped 72.48% to $0.45 after the company filed for voluntary Chapter 11 bankruptcy. Aerohive ...
Tags
ALCS
HIVE
SFLY
From
Benzinga
Apricus Biosciences Announces Notice of Allowance of U.S. Patent Application for RayVa(TM)
October 13, 2014
From
GlobeNewswire News Releases
Apricus Biosciences to Present at the 13th Annual BIO Investor Forum
October 01, 2014
From
GlobeNewswire News Releases
Apricus CEO to Discuss Company's Drug Portfolio, Including Its Topical Cream for Erectile Dysfunction, Vitaros(R), LIVE on iHeart (Clear Channel) Business Talk Radio DFW 1190AM on Sept. 25, 2014
September 24, 2014
Interview to Air at 7:30am EDT / 4:30am PDT / 6:30am CDT on the Traders Network Radio Show, Hosted by Michael Yorba
From
Marketwired News Releases
Apricus Biosciences to Present at the Rodman & Renshaw 16th Annual Global Investment Conference
September 03, 2014
From
GlobeNewswire News Releases
Apricus Biosciences Announces the Launch of Its Topical Treatment for Erectile Dysfunction Vitaros(R) in Germany by Hexal
August 18, 2014
Apricus Continues With Its Series of Ex-US Vitaros(R) Launches Expected Throughout 2014
From
GlobeNewswire News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.